Skip to content
Explore the latest in technology, digital innovation, and i…

The Zimbabwean Government Rejects ‘Lopsided’ US Health Aid Agreement Due to Information Fears

Medical aid image
The offered US financial assistance was intended for initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years over the United States' request for confidential information.

The decision was revealed following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesman later stated that the US was seeking biological samples for scientific study and commercial purposes but was not willing to share the resulting advantages from future medical innovations.

"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for more dialogue to reach a deal suitable to both sides so the nation's critical HIV programme can continue.

Broader Implications

Zimbabwe's decision comes after a comparable case in Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the security of Kenyans' health data.

Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

The agency had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to boost transparency and accountability.

As per reports, Sixteen nations in Africa have to date agreed to these new agreements, representing more than $18.3bn in new funding.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its biological resources and data indefinitely, with no corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," his statement read.

"In essence, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be accessible to our citizens should a future health crisis arise."

National Interest and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting systems already established through the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.

"This framework is designed to ensure that when a country provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage further discussions with our American counterparts on how subsequent co-operation might be structured in a manner that respects the independence and dignity of both nations."

Health Experts Response

Medical experts said it recognised the official position, but recommended that talks must proceed considering much of the nation's HIV programmes were funded by foreign aid.

"If specific concerns exist, such as those involving data governance or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.

The halted deal underscores the complex challenges between receiving much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

The writer

Richard Huang

A tech enthusiast and writer passionate about exploring emerging technologies and sharing practical insights for digital transformation.

Tech Insights Blog

Type to search articles.